Latest debt-to-equity ratio
TScan Therapeutics Debt-to-equity ratio
Direct answer
TScan Therapeutics's debt-to-equity ratio is 131.69%.
The verified market snapshot reports 131.69%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 131.69%
Explore related company data
View TScan Therapeutics's market capitalizationView TScan Therapeutics's price-to-book ratioView TScan Therapeutics's return on equityView TScan Therapeutics's dividend yieldView TScan Therapeutics's 52-week price rangeView TScan Therapeutics's revenue growthView TScan Therapeutics's profit marginView all TScan Therapeutics key metricsReturn to TScan Therapeutics profile